KẾT QUẢ ĐIỀU TRỊ TĂNG TIẾT MỒ HÔI KHU TRÚ BẰNG CẤY CHỈ TẠI BỆNH VIỆN DA LIỄU HÀ NỘI

Abstract

Objective: To evaluate the results of treating localized hyperhidrosis (HDS) by thread implantation at Hanoi Dermatology Hospital, 2019-2020. Subjects and methods: A non-controlled clinical intervention study was conducted on 21 patients with primary localized HDS who received thread implantation treatment at Hanoi Dermatology Hospital from October 2019 to October 2020. The treatment consisted of 4 thread implantations (once every 2 weeks) into selected acupoints; the results were evaluated before treatment, at the third visit, 2 weeks, and 2 months after the end of treatment using the sweat severity score (HDSS) and the DLQI quality of life index. Results: The average HDSS score decreased from 3.33 ± 0.48 before treatment to 2.19 ± 0.60 after 8 weeks of treatment (p < 0.001), corresponding to a ~50% reduction in sweat volume. The average DLQI score decreased from 10.33 ± 1.93 (high impact) to 5.62 ± 2.92 (moderate impact) (p < 0.001). 90.5% of patients were satisfied with the treatment results, no patients were dissatisfied. The rate of ≥ 50% improvement in sweat was 90,5% (of which 4.8% of patients had complete cessation of sweating); 2 patients (9.5%) did not respond. No dangerous late complications were recorded; Early complications were mainly local swelling (14.3%) and mild pain (23.8%), without infection or compensatory hyperhidrosis. Conclusion: Thread implantation is a potential, minimally invasive treatment for hyperhidrosis that has shown good results, significantly reduces sweating levels, improves patient quality of life, and is safe, with almost no significant complications after 2 months of follow-up.